Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Brief Communication
  • Published:

Carbon metabolism–mediated myogenic differentiation

Abstract

The role of nutrients and metabolism in cellular differentiation is poorly understood. Using RNAi screening, metabolic profiling and small-molecule probes, we discovered that the knockdown of three metabolic enzymes—phosphoglycerate kinase (Pgk1), hexose-6-phosphate dehydrogenase (H6pd) and ATP citrate lyase (Acl)—induces differentiation of mouse C2C12 myoblasts even in the presence of mitogens. These enzymes and the pathways they regulate provide new targets for the control of myogenic differentiation in myoblasts and rhabdomyosarcoma cells.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: RNAi screen and effects of CsA and TSA on C2C12 differentiation.
Figure 2: Fluvastatin treatment causes differentiation of human rhabdomyosarcoma cells and inhibits their proliferation and growth on soft agar.

Similar content being viewed by others

References

  1. Loh, Y.H., Ng, J.H. & Ng, H.H. Cell Cycle 7, 885–891 (2008).

    Article  CAS  Google Scholar 

  2. Bolouri, H. & Davidson, E.H. Dev. Biol. 246, 2–13 (2002).

    Article  CAS  Google Scholar 

  3. Yaffe, D. & Saxel, O. Differentiation 7, 159–166 (1977).

    Article  CAS  Google Scholar 

  4. Popanda, O., Fox, G. & Thielmann, H.W. Biochim. Biophys. Acta 1397, 102–117 (1998).

    Article  CAS  Google Scholar 

  5. Ozcan, U. et al. Science 313, 1137–1140 (2006).

    Article  Google Scholar 

  6. Lavery, G.G. et al. J. Biol. Chem. 283, 8453–8461 (2008).

    Article  CAS  Google Scholar 

  7. Nakanishi, K., Dohmae, N. & Morishima, N. FASEB J. 21, 2994–3003 (2007).

    Article  Google Scholar 

  8. Tomida, T. et al. EMBO J. 22, 3825–3832 (2003).

    Article  CAS  Google Scholar 

  9. Schulz, R.A. & Yutzey, K.E. Dev. Biol. 266, 1–16 (2004).

    Article  CAS  Google Scholar 

  10. Rathmell, J.C. & Newgard, C.B. Science 324, 1021–1022 (2009).

    Article  CAS  Google Scholar 

  11. Beigneux, A.P. et al. J. Biol. Chem. 10, 9557–9564 (2004).

    Article  Google Scholar 

  12. Dagher, R. & Helman, L. Oncologist 4, 34–44 (1999).

    CAS  PubMed  Google Scholar 

  13. Tomczak, K.K. et al. FASEB J. 18, 403–405 (2004).

    Article  CAS  Google Scholar 

  14. Barash, V., Erlich, T. & Bashan, N. Biochem. Int. 20, 267–274 (1990).

    CAS  PubMed  Google Scholar 

  15. Hewitt, K.N., Walker, E.A. & Stewart, P.M. Endocrinology 146, 2539–2543 (2005).

    Article  CAS  Google Scholar 

  16. Hatzivassiliou, G. et al. Cancer Cell 8, 311–321 (2005).

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank the RNAi Consortium for shRNAs and the following members of the RNAi platform of the Broad Institute for their scientific advising: A. Derr, J. Grenier, S. Silver, G. Cowley and O. Alkan. We also thank S. Carr, R. Wei, E. Yang and members of the Broad Institute metabolic profiling platform for scientific advice and analysis of metabolite extracts, and J. Nisbet of Children's Hospital Boston for thoughtful comments. This work was supported in part by US Department of Defense Breast Cancer Innovator Award #BC074986 (to D.E.I.) and US National Institute of General Medical Sciences grant 38627 (to S.L.S.). S.L.S. is an investigator with the Howard Hughes Medical Institute. A.L.B. was supported in part by the US National Science Foundation.

Author information

Authors and Affiliations

Authors

Contributions

A.L.B. designed and performed the RNAi screen, all validation experiments, quantitative RT-PCR, generation of stable cell lines and studies on cyclosporin, cholesterol and trichostatin. A.R. designed and performed metabolite experiments and the histone acetylation study. S.L.S. participated in the design of the overall study. S.H., D.E.I. and S.L.S. contributed to the preparation of the manuscript. D.E.I. and A.L.B. conceived of the idea for this study. All authors interpreted data, commented on results and participated in writing the manuscript.

Corresponding authors

Correspondence to Arvind Ramanathan or Stuart L Schreiber.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Supplementary information

Supplementary Text and Figures

Supplementary Figures 1-3, Supplementary Tables 1 and 2, and Supplementary Methods (PDF 780 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bracha, A., Ramanathan, A., Huang, S. et al. Carbon metabolism–mediated myogenic differentiation. Nat Chem Biol 6, 202–204 (2010). https://doi.org/10.1038/nchembio.301

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nchembio.301

This article is cited by

Search

Quick links

Nature Briefing: Cancer

Sign up for the Nature Briefing: Cancer newsletter — what matters in cancer research, free to your inbox weekly.

Get what matters in cancer research, free to your inbox weekly. Sign up for Nature Briefing: Cancer